<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(12)</volume><submitter>Kim K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to evaluate the long-term surgical outcomes of patients with hypertrophic obstructive cardiomyopathy and explore the risk factors for mortality, especially those related to atrial fibrillation.&lt;h4>Methods&lt;/h4>We retrospectively reviewed 150 consecutive patients with hypertrophic obstructive cardiomyopathy who underwent surgical treatment between March 2003 and December 2020.&lt;h4>Results&lt;/h4>Fifty (33.3%, age 53.7±16.1 years) patients underwent isolated septal myectomy (SM), 79 (52.7%, age 52.3±12.6 years) underwent SM with mitral valve intervention (SM + MVI), and 21 (14.0%, age 57.1±13.5 years) underwent SM with mitral valve replacement (SM + MVR). Overall peak left ventricular outflow tract pressure gradient at rest was significantly decreased from 91.9±43.2 to</pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>4624-4632</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9840035</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term outcomes and risk factors for mortality of patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy.</pubmed_title><pmcid>PMC9840035</pmcid><pubmed_authors>Jung SH</pubmed_authors><pubmed_authors>Chung CH</pubmed_authors><pubmed_authors>Kim K</pubmed_authors><pubmed_authors>Choo SJ</pubmed_authors><pubmed_authors>Lee SA</pubmed_authors><pubmed_authors>Kim JB</pubmed_authors><pubmed_authors>Kim HR</pubmed_authors><pubmed_authors>Yoo JS</pubmed_authors><pubmed_authors>Lee JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term outcomes and risk factors for mortality of patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy.</name><description>&lt;h4>Background&lt;/h4>We aimed to evaluate the long-term surgical outcomes of patients with hypertrophic obstructive cardiomyopathy and explore the risk factors for mortality, especially those related to atrial fibrillation.&lt;h4>Methods&lt;/h4>We retrospectively reviewed 150 consecutive patients with hypertrophic obstructive cardiomyopathy who underwent surgical treatment between March 2003 and December 2020.&lt;h4>Results&lt;/h4>Fifty (33.3%, age 53.7±16.1 years) patients underwent isolated septal myectomy (SM), 79 (52.7%, age 52.3±12.6 years) underwent SM with mitral valve intervention (SM + MVI), and 21 (14.0%, age 57.1±13.5 years) underwent SM with mitral valve replacement (SM + MVR). Overall peak left ventricular outflow tract pressure gradient at rest was significantly decreased from 91.9±43.2 to</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-26T10:01:04.634Z</modification><creation>2025-04-06T13:10:34.293Z</creation></dates><accession>S-EPMC9840035</accession><cross_references><pubmed>36647469</pubmed><doi>10.21037/jtd-22-1045</doi></cross_references></HashMap>